share_log

Here's What's Concerning About Kangji Medical Holdings' (HKG:9997) Returns On Capital

Here's What's Concerning About Kangji Medical Holdings' (HKG:9997) Returns On Capital

以下是康基医疗控股(HKG:9997)资本回报率的担忧
Simply Wall St ·  2022/06/25 20:40

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and secondly, an expanding base of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. Having said that, from a first glance at Kangji Medical Holdings (HKG:9997) we aren't jumping out of our chairs at how returns are trending, but let's have a deeper look.

我们应该寻找什么样的趋势,我们想要找出能够长期成倍增值的股票?首先,我们希望看到一个经过验证的退货关于已使用资本(ROCE)的增长,其次是扩张基地已动用资本的比例。这向我们表明,它是一台复合机器,能够不断地将其收益再投资于企业,并产生更高的回报。话虽如此,从第一眼看康吉医疗控股有限公司(HKG:9997)我们不会因为回报率的趋势而从椅子上跳起来,但让我们更深入地看看。

Return On Capital Employed (ROCE): What is it?

资本回报率(ROCE):它是什么?

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. To calculate this metric for Kangji Medical Holdings, this is the formula:

如果您不确定,只需澄清一下,ROCE是一种评估公司投资于其业务的资本获得多少税前收入(按百分比计算)的指标。要计算康基医疗控股的这一指标,公式如下:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

已动用资本回报率=息税前收益(EBIT)?(总资产-流动负债)

0.13 = CN¥418m ÷ (CN¥3.4b - CN¥117m) (Based on the trailing twelve months to December 2021).

0.13=CN元4.18亿?(CN元34亿-CN元1.17亿)(根据截至2021年12月的往绩12个月计算).

Therefore, Kangji Medical Holdings has an ROCE of 13%. On its own, that's a standard return, however it's much better than the 10% generated by the Medical Equipment industry.

所以呢,康基医疗控股的净资产收益率为13%。就其本身而言,这是一个标准的回报,但它比医疗设备行业10%的回报率要好得多。

Check out our latest analysis for Kangji Medical Holdings

查看我们对康吉医疗控股公司的最新分析

SEHK:9997 Return on Capital Employed June 26th 2022
联交所:9997已动用资本回报率2022年6月26日

Above you can see how the current ROCE for Kangji Medical Holdings compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free report on analyst forecasts for the company.

上面你可以看到康吉医疗控股公司目前的净资产收益率与之前的资本回报率相比如何,但你只能从过去知道这么多。如果您感兴趣,您可以在我们的免费分析师对该公司的预测报告。

How Are Returns Trending?

回报趋势如何?

When we looked at the ROCE trend at Kangji Medical Holdings, we didn't gain much confidence. Around four years ago the returns on capital were 59%, but since then they've fallen to 13%. However, given capital employed and revenue have both increased it appears that the business is currently pursuing growth, at the consequence of short term returns. And if the increased capital generates additional returns, the business, and thus shareholders, will benefit in the long run.

当我们观察康基医疗控股的ROCE走势时,我们并没有获得太多信心。大约四年前,资本回报率为59%,但自那以来已降至13%。然而,鉴于已动用资本和收入都有所增加,该业务目前似乎正在追求增长,这是短期回报的结果。如果增加的资本产生额外的回报,从长远来看,企业和股东都将受益。

The Key Takeaway

关键的外卖

In summary, despite lower returns in the short term, we're encouraged to see that Kangji Medical Holdings is reinvesting for growth and has higher sales as a result. And there could be an opportunity here if other metrics look good too, because the stock has declined 41% in the last year. So we think it'd be worthwhile to look further into this stock given the trends look encouraging.

总而言之,尽管短期内回报较低,但我们感到鼓舞的是,康吉医疗控股正在进行再投资以实现增长,并因此实现了更高的销售额。如果其他指标也看起来不错,这可能是一个机会,因为该股在过去一年里下跌了41%。因此,我们认为,鉴于趋势看起来令人鼓舞,进一步研究这只股票是值得的。

One more thing to note, we've identified 1 warning sign with Kangji Medical Holdings and understanding it should be part of your investment process.

还有一件事需要注意,我们已经确定了1个警告标志与康吉医疗控股公司合作,并理解这应该是您投资过程的一部分。

While Kangji Medical Holdings may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.

虽然康基医疗控股目前的回报率可能不是最高的,但我们已经编制了一份目前股本回报率超过25%的公司名单。看看这个免费在这里列出。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发